BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 5675432)

  • 1. The effect of salicylates on the hemostatic properties of platelets in man.
    Weiss HJ; Aledort LM; Kochwa S
    J Clin Invest; 1968 Sep; 47(9):2169-80. PubMed ID: 5675432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of salicylate on platelets and whole blood adenine nucleotides.
    Davies DT; Hughes A; Tonks RS
    Br J Pharmacol; 1969 Jul; 36(3):437-47. PubMed ID: 5789804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-platelet actions of salicylates: in vivo, ex vivo and in vitro effects of choline salicylate].
    Irino O; Saitoh K; Ohkubo K
    Nihon Yakurigaku Zasshi; 1985 Jul; 86(1):17-23. PubMed ID: 4043866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of platelets to aspirin in von Willebrand's disease.
    Leslie J; Mason DY
    J Clin Pathol; 1970 Sep; 23(6):526-8. PubMed ID: 5312233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men.
    Mohri H; Ohkubo T
    Ann Pharmacother; 1993 Apr; 27(4):405-10. PubMed ID: 8477113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acetylsalicyclic acid on platelet function.
    Evans G; Packham MA; Nishizawa EE; Mustard JF; Murphy EA
    J Exp Med; 1968 Nov; 128(5):877-94. PubMed ID: 4176225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic catheters.
    Cattaneo M; Chahil A; Somers D; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Blood; 1983 Feb; 61(2):353-61. PubMed ID: 6821701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between sodium salicylate and acetyl salicylic acid evaluated using ADP induced platelet aggregation and bleeding time.
    Ring T; Dyerberg J
    Thromb Res; 1985 Jun; 38(6):687-93. PubMed ID: 4024050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?
    Danesh BJ; McLaren M; Russell RI; Lowe GD; Forbes CD
    Scott Med J; 1988 Aug; 33(4):315-6. PubMed ID: 3187504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salicylates on human platelets.
    O'Brien JR
    Lancet; 1968 Apr; 1(7546):779-83. PubMed ID: 4171129
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man.
    Jones EW; Cockbill SR; Cowley AJ; Hanley SP; Heptinstall S
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):39S-44S. PubMed ID: 6401999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease.
    Weiss HJ; Tschopp TB; Baumgartner HR
    N Engl J Med; 1975 Sep; 293(13):619-23. PubMed ID: 1080251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diflunisal on platelet function and fecal blood loss.
    Green D; Davies RO; Holmes GI; Kohl H; Lee RB; Reynolds N; Schmid FR; Ts'ao C
    Clin Pharmacol Ther; 1981 Sep; 30(3):378-84. PubMed ID: 6974077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin in vivo and in vitro on plasma cofactors of platelet aggregation.
    Okonkwo P; Sise HS
    Thromb Diath Haemorrh; 1971 Jun; 25(2):279-87. PubMed ID: 5568047
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemostatic effects of salsalate in normal subjects and patients with hemophilia A.
    Sweeney JD; Hoernig LA
    Thromb Res; 1991 Jan; 61(1):23-7. PubMed ID: 2020937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.